tiprankstipranks
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE

Compare Ultragenyx Pharmaceutical (RARE) vs. Competitors

1,216 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Ultragenyx Pharmaceutical
$23.30
$2.25B
-3.94
-29.73%
16 Buy
2 Hold
0 Sell
Strong Buy
Travere Therapeutics
$28.96
$2.67B
-67.82
114.68%
10 Buy
2 Hold
0 Sell
Strong Buy
Xenon
$58.40
$5.57B
-10.27
90.04%
19 Buy
0 Hold
0 Sell
Strong Buy
Disc Medicine
$66.32
$2.53B
-13.21
88.25%
10 Buy
0 Hold
0 Sell
Strong Buy
Tarsus Pharmaceuticals
$72.56
$3.09B
-51.51
64.46%
8 Buy
1 Hold
0 Sell
Strong Buy
Mineralys Therapeutics, Inc.
$26.62
$2.19B
-15.88
118.38%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RARE
Ultragenyx Pharmaceutical
23.30
-11.62
-33.28%
TVTX
Travere Therapeutics
28.96
14.13
95.28%
XENE
Xenon
58.40
24.96
74.64%
IRON
Disc Medicine
66.32
26.05
64.69%
TARS
Tarsus Pharmaceuticals
72.56
23.84
48.93%
MLYS
Mineralys Therapeutics, Inc.
26.62
12.70
91.24%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts